GE, Biosense Alliance Enhances Ultrasound Use in Electrophysiology

 

May 20, 2008

May 20, 2008 — GE Healthcare is expanding its strategic alliance with Biosense Webster to develop real-time ultrasound imaging for use in electrophysiology procedures, enabling interventional procedures like ablation for arrythmia.

The agreement, announced at the the Heart Rhythm Society (HRS) meeting in San Francisco, builds on the same relationship that integrated GE Healthcare’s CardioLabÒIT Recording System and Biosense Webster’s Carto Mapping System. GE demonstrated at HRS the CardioLab IT -Carto XP workflow integration. According to Mark Langer, general manager of GE Healthcare Interventional Cardiovascular Ultrasound business, better visualization technologies can enable the use of ablation for treating abnormal heart rhythms that, according to the American Heart Association, account for 20% of heart disease deaths.

“This new step in our alliance is a natural extension of our long-standing technology partnership with Biosense Webster,” said Langer. “In this new development, we are integrating GE’s capabilities in high performance ultrasound imaging with the leading EP catheter technologies from Biosense Webster. Together, we will create new imaging solutions for intracardiac therapies, augmenting current technologies with new real-time visualization of the cardiac anatomy and therapy catheters.”


For more information: www.gehealthcare.com